SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001032210-00-000577
Filing Date
2000-03-23
Accepted
2000-03-23 00:00:00
Documents
11
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 196849
2 FORM OF INDEMNIFICATION AGREEMENT EX-10.1 18048
3 GENE TRANSFER TECHNOLOGY LICENSE AGREEMENT EX-10.3 40330
4 PHS PATENT LICENSE AGREEMENT-NON-EXCLUSIVE EX-10.4 41121
5 PATENT LICENSE AGREEMENT EX-10.5 37459
6 LICENSE AGREEMENT WITH UNIVERSITY OF N. CAROLINA EX-10.17 17289
7 OLIVE WAY BUILDING LEASE EX-10.29 135529
8 SUBSIDIARIES EX-21.1 354
9 CONSENT OF ERNST & YOUNG LLP EX-23.1 1729
10 FINANCIAL DATA SCHEDULE EX-27.1 2048
11 EMERALD GENE SYSTEMS FINANCIAL DATA SCHEDULE EX-27.2 2061
  Complete submission text file 0001032210-00-000577.txt   495366
Mailing Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612
TARGETED GENETICS CORP /WA/ (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23930 | Film No.: 577015
SIC: 2836 Biological Products, (No Diagnostic Substances)